421
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Risk factors of central nervous system relapse in mantle cell lymphoma

, , , , , , , , , , & show all
Pages 1908-1914 | Received 05 Oct 2012, Accepted 11 Jan 2013, Published online: 20 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Chiara Rusconi & Carlo Visco. (2023) Putting the brain into mantle cell lymphoma. Leukemia & Lymphoma 64:2, pages 259-260.
Read now
Milena Kohn, Alexandre Karras, Mohamad Zaidan, Charles Bénière, Jean-Baptiste de Fréminville, Kamel Laribi, Marie Claire Perrin, Marion Malphettes, Ronan Le Calloch, Bruno Anglaret, Juliana Martiniuc, Sarah Bailly, Sylvie Chevret, Thierry Molina, Eric Thervet & Catherine Thieblemont. (2020) Lymphomas with kidney involvement: the French multicenter retrospective LyKID study. Leukemia & Lymphoma 61:4, pages 887-895.
Read now
Vijaya R. Bhatt, Fausto R. Loberiza$suffix/text()$suffix/text(), Lynette M. Smith, James O. Armitage, Timothy C. Greiner, Martin Bast, Matthew A. Lunning, Philip J. Bierman, Julie M. Vose & R. Gregory Bociek. (2016) Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience. Leukemia & Lymphoma 57:6, pages 1327-1334.
Read now
Rajesh Shrestha, Vijaya Raj Bhatt, Guru Subramanian Guru Murthy & James O. Armitage. (2015) Clinicopathologic features and management of blastoid variant of mantle cell lymphoma. Leukemia & Lymphoma 56:10, pages 2759-2767.
Read now
Martin Dreyling, Virginia Amador, Mary Callanan, Mats Jerkeman, Steven Le Gouill, Christiane Pott, Simon Rule & Francesco Zaja. (2015) Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network. Leukemia & Lymphoma 56:4, pages 866-876.
Read now
Giulia Benevolo, Annalisa Chiappella & Umberto Vitolo. (2013) The risk of CNS involvement in aggressive lymphomas in the rituximab era. Expert Review of Hematology 6:6, pages 643-652.
Read now
Andre Goy. (2013) Mantle cell lymphoma: continuously improving the odds!. Expert Opinion on Orphan Drugs 1:12, pages 1001-1018.
Read now
Chan Yoon Cheah & John F. Seymour. (2013) Refining the predictors of risk for central nervous system involvement in patients with mantle cell lymphoma. Leukemia & Lymphoma 54:9, pages 1859-1861.
Read now
Jeanette K Doorduijn & Hanneke C Kluin-Nelemans. (2013) Management of mantle cell lymphoma in the elderly patient. Clinical Interventions in Aging 8, pages 1229-1236.
Read now

Articles from other publishers (26)

Tingxun Lu, Jie Zhang, Jenna M. McCracken & Ken H. Young. (2024) Recent advances in genomics and therapeutics in mantle cell lymphoma. Cancer Treatment Reviews 122, pages 102651.
Crossref
Juan Pablo Alderuccio, Lakshmi Nayak & Kate Cwynarski. (2023) How I treat secondary CNS involvement by aggressive lymphomas. Blood 142:21, pages 1771-1783.
Crossref
Toby A. Eyre, Mark J. Bishton, Rory McCulloch, Maeve O'Reilly, Robin Sanderson, Geetha Menon, Sunil Iyengar, David Lewis, Jonathan Lambert, Kim M. Linton & Pamela McKay. (2023) Diagnosis and management of mantle cell lymphoma: A British Society for Haematology Guideline. British Journal of Haematology.
Crossref
Khoan Vu & Matthew J. Frank. (2023) CAR T-cell therapy for mantle cell lymphoma with central nervous system relapse. Blood Advances 7:3, pages 375-378.
Crossref
Mattia Novo & Corrado Benevolo Savelli. 2023. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Chiara Rusconi, Chan Y. Cheah, Toby A. Eyre, David Tucker, Pavel Klener, Eva Giné, Lara Crucitti, Cristina Muzi, Sara Iadecola, Gabriele Infante, Sophie Bernard, Rebecca L. Auer, Chiara Pagani, Monika Duglosz-Danecka, Heidi Mocikova, Tom van Meerten, Emanuele Cencini, Ana Marin-Niebla, Michael E. Williams, Piera Angelillo, Paolo Nicoli, Annalisa Arcari, Lucia Morello, Donato Mannina, Orsola Vitagliano, Roberto Sartori, Annalisa Chiappella, Roberta Sciarra, Piero M. Stefani, Martin Dreyling, John F. Seymour & Carlo Visco. (2022) Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse. Blood 140:17, pages 1907-1916.
Crossref
Furqaan Ahmed Kaji, Nicolás Martinez‐Calle, Vishakha Sovani & Christopher Paul Fox. (2022) Rare central nervous system lymphomas. British Journal of Haematology 197:6, pages 662-678.
Crossref
Toby A. Eyre, Chan Y. Cheah & Michael L. Wang. (2022) Therapeutic options for relapsed/refractory mantle cell lymphoma. Blood 139:5, pages 666-677.
Crossref
Alan L. Myers, Jitesh D. Kawedia, Ahmed Nader, Jason R. Westin & Brandon R. Shank. (2019) A rare case of methotrexate and primaquine co‐administration in a mantle cell lymphoma patient. Journal of Clinical Pharmacy and Therapeutics 44:5, pages 800-804.
Crossref
Adalgisa Condoluci, Davide Rossi, Emanuele Zucca & Franco Cavalli. (2018) Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma. Current Oncology Reports 20:10.
Crossref
Pamela McKay, Mike Leach, Bob Jackson, Stephen Robinson & Simon Rule. (2018) Guideline for the management of mantle cell lymphoma. British Journal of Haematology 182:1, pages 46-62.
Crossref
Pamela McKay, Mike Leach, Bob Jackson, Stephen Robinson & Simon Rule. (2018) A British Society for haematology good practice paper on the diagnosis and investigation of patients with mantle cell lymphoma. British Journal of Haematology 182:1, pages 63-70.
Crossref
J.J. Alonso, A. Cánovas & M.M. Riñón. (2018) Late-onset meningeal lymphomatosis in mantle cell lymphoma controlled with chemotherapy. Neurología (English Edition) 33:3, pages 201-202.
Crossref
J.J. Alonso, A. Cánovas & M.M. Riñón. (2018) Linfomatosis meníngea tardía en linfoma del manto controlada con quimioterapia. Neurología 33:3, pages 201-202.
Crossref
Peter Martin. (2017) Optimizing therapy for mantle cell lymphoma. Hematology 2017:1, pages 304-309.
Crossref
Sai Ravi Pingali & Timothy S. Fenske. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 402 416 .
. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 361 444 .
D. Chihara, N. Asano, K. Ohmachi, M. Nishikori, M. Okamoto, M. Sawa, R. Sakai, Y. Okoshi, N. Tsukamoto, Y. Yakushijin, S. Nakamura, T. Kinoshita, M. Ogura & R. Suzuki. (2015) Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL). Annals of Oncology 26:5, pages 966-973.
Crossref
Simone Ferrero & Martin Dreyling. 2015. Management of Hematological Cancer in Older People. Management of Hematological Cancer in Older People 143 168 .
M Dreyling, S Ferrero & O Hermine. (2014) How to manage mantle cell lymphoma. Leukemia 28:11, pages 2117-2130.
Crossref
Chan Yoon Cheah, John F Seymour & Michael Dickinson. (2014) Ongoing challenge of optimal patient selection for CNS prophylaxis in patients with non-Hodgkin lymphoma. International Journal of Hematologic Oncology 3:3, pages 189-201.
Crossref
Géraldine Faivre, Julien Lagarde, Sylvain Choquet, Elisabeth Maillart & Catherine Lubetzki. (2014) CNS involvement at diagnosis in mantle cell lymphoma with atypical MRI features. Journal of Neurology 261:5, pages 1018-1020.
Crossref
Michael E. Williams, L. Kyle Brett, Martin Dreyling, German Ott & Eric D. Hsi. 2014. Rare Lymphomas. Rare Lymphomas 277 302 .
Kathrin Aprile von Hohenstaufen, Annarita Conconi, Cassio Polpo de Campos, Silvia Franceschetti, Francesco Bertoni, Gloria Margiotta Casaluci, Anastasios Stathis, Michele Ghielmini, Georg Stussi, Franco Cavalli, Gianluca Gaidano & Emanuele Zucca. (2013) Prognostic impact of monocyte count at presentation in mantle cell lymphoma. British Journal of Haematology 162:4, pages 465-473.
Crossref
C.Y. Cheah, A. George, E. Giné, A. Chiappella, H.C. Kluin-Nelemans, W. Jurczak, K. Krawczyk, H. Mocikova, P. Klener, D. Salek, J. Walewski, M. Szymczyk, L. Smolej, R.L. Auer, D.S. Ritchie, L. Arcaini, M.E. Williams, M. Dreyling & J.F. Seymour. (2013) Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network. Annals of Oncology 24:8, pages 2119-2123.
Crossref
Giulia Benevolo, Annalisa Chiappella & Umberto Vitolo. (2013) XVI. CNS prophylaxis in aggressive lymphomas: for whom and how. Hematological Oncology 31:S1, pages 89-91.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.